Paclitaxel
I213
Phase 2 small_molecule completed
Quick answer
Paclitaxel for Metastatic Breast Cancer is a Phase 2 program (small_molecule) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ONCOLYTICS BIOTECH INC
- Indication
- Metastatic Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed